| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $8.8M | -34.7% |
| Cost of Revenue | $2.9M | -31.0% |
| Gross Profit | $5.9M | -36.4% |
| R&D Expense | $5.5M | -38.0% |
| SG&A Expense | $4.3M | -14.8% |
| Operating Income | -$6.6M | +77.0% |
| Pre-tax Income | -$6.4M | +77.6% |
| Income Tax | $0 | — |
| Net Income | -$6.4M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -67.1% |
| Accounts Receivable | $723K | -50.3% |
| Current Assets | $3.5M | -54.8% |
| Total Assets | $15.6M | -35.9% |
| Current Liabilities | $2.4M | -70.1% |
| Total Liabilities | $4.0M | -69.2% |
| Stockholders' Equity | $11.5M | +2.8% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.2M | +43.1% |
| Investing Cash Flow | -$1.5M | +56.7% |
| Financing Cash Flow | $3.0M | +4390.2% |
| +77.6% |
| EPS (Basic) | -$0.38 | +81.5% |
| EPS (Diluted) | -$0.38 | +81.5% |